ABT
Abbott Laboratories
Stock
$96.69−2.14 (−2.17%)Close Oct 1, 2026
Key figures
| Metric | TTM | YoY |
|---|---|---|
| Revenue | $46.6B | +8.1% |
| Gross profit | $26.4B | +9.2% |
| Operating income | $7.3B | −2.2% |
| Net income | $5.4B | −61.2% |
| EPS | $3.11 | −61.0% |
| Free cash flow | $7.8B | +15.5% |
Abbott Laboratories
$96.69−2.14 (−2.17%)Close Oct 1, 2026
| Metric | TTM | YoY |
|---|---|---|
| Revenue | $46.6B | +8.1% |
| Gross profit | $26.4B | +9.2% |
| Operating income | $7.3B | −2.2% |
| Net income | $5.4B | −61.2% |
| EPS | $3.11 | −61.0% |
| Free cash flow | $7.8B | +15.5% |